Login / Signup

Risk of renal failure with the non-vitamin K antagonist oral anticoagulants: systematic review and meta-analysis.

Daniel CaldeiraNilza GonçalvesFausto J PintoJoão CostaJoaquim J Ferreira
Published in: Pharmacoepidemiology and drug safety (2015)
NOACs had a similar risk of renal failure compared with VKA/LMWH in phase III RCTs. Post-marketing surveillance should be warranted.
Keyphrases
  • oral anticoagulants
  • phase iii
  • atrial fibrillation
  • open label
  • clinical trial
  • public health
  • phase ii
  • double blind
  • placebo controlled
  • randomized controlled trial
  • study protocol